Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Neurology · Autosomal Dominant Striatal Degeneration

Mapping the Brain: MRI and Diagnostic Clues

At a Glance

ADSD is diagnosed by combining movement symptoms, family history, expert MRI review, and PDE8B genetic testing. Striatal signal changes may support the diagnosis, but MRI or research-only diffusion imaging cannot confirm it alone, and an uncertain gene result is not diagnostic.

Diagnosing Autosomal Dominant Striatal Degeneration (ADSD) is a challenge because it belongs to a group of conditions that look very similar on the surface. Because it is so rare, the diagnosis is usually reached by combining your clinical symptoms, a detailed look at your brain imaging (MRI), and genetic confirmation [1][2].

The MRI: A Window into the Striatum

The striatum is the part of the brain most affected by the PDE8B mutation. While a standard MRI might look “normal” to an untrained eye, specialists look for subtle changes in the signal intensity (brightness or darkness) of this region.

  • T1 and T2 Signals: In the few families studied, symptomatic patients often show an “inhomogeneous increased signal” on T1-weighted images [1]. On T2-weighted images, doctors may see hyperintensity—essentially “bright spots”—in the striatum [2].
  • A Shift Over Time: Interestingly, researchers have found that imaging looks different depending on the stage of the disease. In one study, a person carrying the gene but showing no symptoms actually had a decreased signal on T1 imaging, which eventually turned into an increased signal as the disease progressed [1].
  • DTI (Diffusion Tensor Imaging): This is a specialized type of MRI that looks at the “wiring” or white matter of the brain. In ADSD, DTI can reveal that the fibers connecting different parts of the striatum (the caudate and lentiform nuclei) are disturbed or less dense than they should be [1]. These changes can sometimes be seen even in family members who do not yet have movement symptoms [1]. These findings are reported observations from limited cases, and DTI is a research technique rather than a validated clinical biomarker.

Differentiating ADSD from Other Conditions

Because ADSD causes parkinsonism (slowness and stiffness), it is frequently misdiagnosed as other, more common neurological disorders. Your doctor will look for “clues” that point away from these conditions and toward ADSD. Note: The table below is illustrative and not a self-diagnosis tool. Symptoms and MRI findings vary.

Condition Common MRI Findings Key Differences from ADSD
Parkinson’s Disease (PD) Often appears normal on standard MRI [3]. PD usually involves a resting tremor (though it may lack it) and responds well to levodopa; reported cases of ADSD often have no tremor [1].
Progressive Supranuclear Palsy (PSP) Atrophy (shrinking) of the midbrain, sometimes called the “hummingbird sign” [4]. PSP often includes early eye-movement problems and frequent backward falls [5].
Multiple System Atrophy (MSA) Shrinking of the pons or cerebellum; sometimes a “hot cross bun sign” [6]. MSA typically involves severe “autonomic” issues, like major blood pressure drops or bladder control problems [7].
Corticobasal Syndrome (CBS) Asymmetric shrinking of the top of the brain (parietal lobes) [8]. CBS is usually very lopsided, affecting one side of the body much more than the other [9].

The Path to a Clear Answer

The biggest hurdle to a correct diagnosis is the rarity of the disease. Most neurologists will first rule out the more common causes of parkinsonism. ADSD is usually “on the radar” only when there is a strong family history of similar symptoms or when the MRI shows those specific striatal signal changes that don’t fit other diseases [1][2]. Other clinically relevant causes of adult-onset parkinsonism/ataxia (like medication-induced symptoms, Wilson disease, Huntington disease, or vascular causes) should also be considered.

If your MRI shows isolated changes in the striatum and your genetic test confirms a pathogenic or likely pathogenic PDE8B mutation, it provides a definitive explanation for your symptoms [2]. While the imaging findings help confirm the diagnosis, they are also useful “baselines” that your doctor can use to track the slow progression of the condition over the years. A Variant of Uncertain Significance (VUS) should not be treated as confirmation.

Common questions in this guide

What MRI changes can occur in autosomal dominant striatal degeneration?
Specialists may see subtle signal changes in the striatum, including increased signal on T1-weighted images and bright areas on T2-weighted images. The pattern may change as the disease progresses, and a routine MRI can look normal to someone without imaging expertise. These findings have been reported in only a small number of families.
Can a normal MRI rule out ADSD?
No. MRI findings can be subtle or depend on disease stage, so diagnosis is not based on a scan alone. Doctors combine symptoms, family history, expert imaging review, and PDE8B genetic testing.
What does a PDE8B test show when ADSD is suspected?
A pathogenic or likely pathogenic PDE8B variant, together with compatible symptoms and isolated striatal imaging changes, can provide a definitive explanation for ADSD. A variant of uncertain significance means the change is not yet understood and should not be treated as confirmation.
Is DTI a standard test for diagnosing ADSD?
DTI is a specialized MRI method that may show disrupted or less-dense fibers between parts of the striatum, sometimes before movement symptoms appear. It remains a research technique rather than a validated clinical biomarker, so it cannot diagnose ADSD by itself.
How do doctors distinguish ADSD from Parkinson’s disease and similar disorders?
Clinicians compare symptoms, family history, MRI patterns, and genetic results. Reported ADSD cases often lack a resting tremor and may show striatal signal changes, while Parkinson’s disease often has a normal standard MRI and usually responds well to levodopa; neither pattern is diagnostic by itself. Progressive supranuclear palsy, multiple system atrophy, corticobasal syndrome, and other causes have different clinical or imaging clues, so a neurologist must interpret the full picture.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific findings were noted in my striatum on the T1 and T2 weighted MRI sequences?
  2. 2.Does my imaging show signs of midbrain or cerebellar atrophy, which might suggest a different condition like PSP or MSA?
  3. 3.If DTI was performed, did it show any disruption in the fibers connecting the different parts of the basal ganglia?
  4. 4.How do my MRI results compare to the 'inhomogeneous increased signal' reported in other PDE8B cases?
  5. 5.Is there any sign of 'iron deposition' or other metabolic changes in my basal ganglia that would point to a different diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Clinical findings of autosomal-dominant striatal degeneration and PDE8B mutation screening in parkinsonism and related disorders.

    Ni J, Yi X, Liu Z, et al.

    Parkinsonism & related disorders 2019; (69()):94-98 doi:10.1016/j.parkreldis.2019.11.002.

    PMID: 31726290
  2. 2

    A novel mutation of PDE8B Gene in a Japanese family with autosomal-dominant striatal degeneration.

    Azuma R, Ishikawa K, Hirata K, et al.

    Movement disorders : official journal of the Movement Disorder Society 2015; (30(14)):1964-7 doi:10.1002/mds.26345.

    PMID: 26769607
  3. 3

    Parkinson's disease.

    Kalia LV, Lang AE

    Lancet (London, England) 2015; (386(9996)):896-912.

    PMID: 25904081
  4. 4

    The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism.

    Mueller C, Hussl A, Krismer F, et al.

    Parkinsonism & related disorders 2018; (54()):90-94 doi:10.1016/j.parkreldis.2018.04.005.

    PMID: 29643007
  5. 5

    Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis.

    Albrecht F, Bisenius S, Neumann J, et al.

    NeuroImage. Clinical 2019; (22()):101722 doi:10.1016/j.nicl.2019.101722.

    PMID: 30831462
  6. 6

    Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: a pilot study.

    Painous C, Pascual-Diaz S, Muñoz-Moreno E, et al.

    European radiology 2023; (33(7)):4540-4551 doi:10.1007/s00330-023-09435-0.

    PMID: 36773046
  7. 7

    Conventional Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Disorders: A Meta-Analysis.

    Lee W

    Movement disorders clinical practice 2021; (8(2)):217-223 doi:10.1002/mdc3.13070.

    PMID: 33553491
  8. 8

    Atypical Parkinsonian Syndromes: Structural, Functional, and Molecular Imaging Features.

    Keir G, Roytman M, Mashriqi F, et al.

    AJNR. American journal of neuroradiology 2024; (45(12)):1865-1877 doi:10.3174/ajnr.A8313.

    PMID: 39209485
  9. 9

    Neuropathology and emerging biomarkers in corticobasal syndrome.

    Koga S, Josephs KA, Aiba I, et al.

    Journal of neurology, neurosurgery, and psychiatry 2022; doi:10.1136/jnnp-2021-328586.

    PMID: 35697501

This page explains MRI and genetic testing findings in ADSD for informational purposes only and does not constitute medical advice. A neurologist and genetics team should interpret your results.

Get notified when new evidence is published on Autosomal dominant striatal neurodegeneration.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.